Compare Abbott Laboratories (ABT) vs Suncor Energy Inc. (SU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Suncor Energy Inc. — how do they compare? Abbott Laboratories trades at $95.16 (market cap $166.94B), while Suncor Energy Inc. trades at $58.52 (market cap $66.94B). The key difference: Abbott Laboratories is far larger — about 2.5× Suncor Energy Inc.'s market cap, and Suncor Energy Inc. pays the higher dividend (2.98%). Which is the better fit depends on your goals.
| ABT | SU | |
|---|---|---|
Market Cap | $166.94B | $66.94B |
Sector | Health | Energy |
52-Week High | $136.62 | $69.73 |
52-Week Low | $82.57 | $38.17 |
Enterprise Value | $193.69B | $75.07B |
Dividend Yield | 2.63% | 2.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Suncor Energy (SU) trades at $56.66, up 2.92% today, with a bullish technical signal despite mixed moving averages. The stock shows solid fundamentals with a P/E of 14.82, net margin of 11.62%, and consistent dividend payments, including a recent $0.60 distribution. Recent earnings beat expectations in Q3 and Q4 2025, though Q1 2026 missed estimates. Analyst consensus is strongly positive with 74% buy ratings.
Outlook remains favorable due to attractive valuation and strong cash flow, but risks include oil price volatility and operational incidents like the recent Sarnia refinery fire. Earnings growth and disciplined capital allocation are key catalysts for upside, while macroeconomic pressures pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
